Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations

World Health Organization

Altmetrics

Share

Citation

World Health Organization. (‎2017)‎. Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations. World Health Organization. https://apps.who.int/iris/handle/10665/255887. License: CC BY-NC-SA 3.0 IGO

Description

40 p.

Gov't Doc #

WHO/HIV/2017.23

Language

English

Collections

Technical Documents

Metadata

Show full item record

Show Statistical Information

Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations

View/Open

Rights

View Statistics